Menisy (Betahistine Dihydrochloride)

Betahistine acts as a partial agonist at histamine H1 receptors and blocks H3 receptors. This dual action increases histamine release, causing vasodilation of the vessels in the inner ear, which normalises endolymphatic pressure and alleviates vestibular symptoms.

The appropriate dose of Menisy is determined by the prescribing healthcare professional based on the individual’s condition, age, and response. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for betahistine in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To request Menisy, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with conventional antihistamines, betahistine’s H3‑antagonist activity increases histamine release, offering a unique vasodilatory effect on the inner ear. This mechanism can be more effective for Ménière’s disease than simple antihistamine therapy, which primarily blocks H1 receptors.

Menisy should be stored at room temperature, below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Menisy is taken orally, usually with water. The tablets are swallowed whole and should be taken as directed by the prescriber, typically with or without food depending on individual tolerance.

Serious risks, though rare, include severe allergic reactions such as anaphylaxis, marked hypotension, and cardiac arrhythmias. Patients experiencing difficulty breathing, swelling of the face or throat, or a sudden drop in blood pressure should seek immediate medical attention.

Menisy is contraindicated in individuals with known hypersensitivity to betahistine or any of its excipients. It should also be avoided in patients with uncontrolled hypertension, severe cardiac disease, or those taking medications that may cause dangerous interactions without close monitoring.